You are using an older browser version. Please use a supported version for the best MSN experience.

Biogen’s Alzheimer’s Revelation Isn’t So Simple

Investors were shocked to learn that Biogen now plans to pursue regulatory approval for the experimental Alzheimer’s disease drug they previously pulled the plug on. But Heard on the Street's Charley Grant explains why the optimism may be premature. Photo: Brian Snyder/Reuters

UP NEXT

UP NEXT

Latest

Sport

Editor's Picks

World

image beaconimage beaconimage beacon